The mechanism of BV’s targeted clearance of HIV is likely based on the characteristic overexpression of CD30 in CD4+ T cells with latent HIV infection in a suppressive antiretroviral (AR) environment. The gene discussed is TNFRSF8; the disease is HIV infectious disease.